Assessment of severity in colitis: a preliminary study.

Gut
J E Lennard-JonesC C Spicer

Abstract

Clinical features, alone and in combinations of up to five, noted early in patients during 181 admissions to one hospital for treatment of acute colitis over five years, have been correlated with the success or failure of drug treatment as judged by death during medical treatment or the need for urgent surgical treatment. Many of the 56 clinical features studied were of no value in predicting the outcome of the attack. The four features of greatest predictive value were the maximum daily body temperature, the maximum daily pulse rate, the bowel frequency and plasma albumin. The simplest and most discriminating prediction at the end of the first 24 hours in hospital was obtained by combining observations on maximum body temperature and the number of stools passed. Serial observations of temperature or pulse rate over the first four days in hospital gave more prognostic information than observations confined to the first day. The predictive value of certain other features, such as x-ray appearances, is described. A simple classification of severity in acute colitis is proposed from these results as a basis for prospective testing in other hospitals.

References

Feb 1, 1966·Gut·J M WattsJ C Goligher
Oct 29, 1955·British Medical Journal·S C TRUELOVE, L J WITTS
Dec 1, 1963·Gut·F C EDWARDS, S C TRUELOVE

❮ Previous
Next ❯

Citations

Sep 26, 2008·Inflammatory Bowel Diseases·Gunnar Järnerot
Aug 6, 2008·Inflammatory Bowel Diseases·Ashwin N AnanthakrishnanDavid G Binion
Jul 21, 2010·Inflammatory Bowel Diseases·Dan Turner, Anne M Griffiths
Apr 8, 2011·Inflammatory Bowel Diseases·Míriam MañosaEugeni Domènech
Jul 1, 1987·Digestive Diseases and Sciences·K D LindorS J Beaver
Nov 1, 1980·Digestive Diseases and Sciences·R CaprilliG Frieri
May 25, 1977·Gastrointestinal Radiology·C I Bartram
Sep 4, 2008·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Bruce E Sands
Jun 6, 2007·Current Treatment Options in Gastroenterology·Stephen B Hanauer, Arnold Wald
Oct 29, 2013·Best Practice & Research. Clinical Gastroenterology·Francisco Portela, Paula Lago
Feb 20, 2004·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·R N Fedorak
Sep 1, 2000·European Journal of Internal Medicine·B Moum
Jul 5, 2008·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·F RizzelloP Gionchetti
Feb 3, 2007·Nature Clinical Practice. Gastroenterology & Hepatology·Renzo CaprilliGiovanni Latella
Jun 6, 2002·Alimentary Pharmacology & Therapeutics·M DapernoA Pera
Jun 1, 1997·Alimentary Pharmacology & Therapeutics·G M Hyde, D P Jewell
Nov 26, 1999·Alimentary Pharmacology & Therapeutics·G FrieriR Caprilli
Mar 29, 2000·Alimentary Pharmacology & Therapeutics·F CarbonnelJ P Gendre
Aug 29, 2000·Inflammatory Bowel Diseases·B Blomberg, G Järnerot
Sep 1, 1992·British Journal of Clinical Pharmacology·B Crotty, D P Jewell
Oct 16, 2004·Journal of Gastroenterology and Hepatology·Sanjay KumarGourdas Choudhuri
Jan 1, 1996·The Australian and New Zealand Journal of Surgery·G L Hill, M E Neill
Oct 29, 2008·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·S R BrownUNKNOWN ACPGBI
Jun 1, 1996·Gut·S P TravisD P Jewell
Jul 1, 1976·Journal of Clinical Pathology·E MallasW T Cooke
Mar 3, 1998·Lancet·S G Sheth, J T LaMont
Mar 1, 2008·Journal of Crohn's & Colitis·E F StangeUNKNOWN European Crohn's and Colitis Organisation (ECCO)
Mar 1, 2008·Journal of Crohn's & Colitis·S P L TravisUNKNOWN European Crohn's and Colitis Organisation (ECCO)
Sep 1, 2008·Journal of Crohn's & Colitis·Renzo CaprilliGiuseppe Frieri
Apr 1, 1988·World Journal of Surgery·P R Hawley
Jan 1, 1993·Scandinavian Journal of Gastroenterology·J Kjeldsen, O B Schaffalitzky de Muckadell
Jan 1, 1977·Scandinavian Journal of Gastroenterology·J Powell-TuckJ E Lennard-Jones
Mar 1, 1996·Scandinavian Journal of Gastroenterology·E LangholzV Binder
Dec 17, 2014·Expert Review of Gastroenterology & Hepatology·Nicholas T VenthamIan D Arnott
Aug 14, 2009·Expert Review of Gastroenterology & Hepatology·Glen A Doherty, Adam S Cheifetz
Jan 29, 2008·Expert Opinion on Pharmacotherapy·Agnès BaudetJean-Marie Reimund
Oct 1, 1991·Annals of Medicine·H R Dalton, D P Jewell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.